By Nelson                                               S.B. No. 13
         77R1009 PB-D                           
                                A BILL TO BE ENTITLED
 1-1                                   AN ACT
 1-2     relating to a prohibition of discrimination in the determination of
 1-3     eligibility for employment, occupational licenses, and health
 1-4     insurance coverage based on the use of certain genetic
 1-5     characteristics.
 1-6           BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 1-7           SECTION 1. Section 21.401, Labor Code, is amended to read as
 1-8     follows:
 1-9           Sec. 21.401.  DEFINITIONS. In this subchapter:
1-10                 (1)  "DNA" means deoxyribonucleic acid.
1-11                 (2)  "Genetic characteristic" means a scientifically or
1-12     medically identifiable gene or chromosome, or an alteration of such
1-13     a gene or chromosome, that:
1-14                       (A)  is scientifically or medically believed to:
1-15                             (i)  predispose an individual to a disease,
1-16     disorder, or syndrome; or
1-17                             (ii)  be associated with a statistically
1-18     significant increased risk of development of a disease, disorder,
1-19     or syndrome; and
1-20                       (B)  is not associated with any symptom of an
1-21     ongoing disease, disorder, or syndrome affecting an individual on
1-22     the date that genetic information is obtained regarding that
1-23     individual.
1-24                 (3)  "Genetic information" means information that is:
 2-1                       (A)  obtained from or based on a scientific or
 2-2     medical determination of the presence or absence in an individual
 2-3     of a genetic characteristic; or
 2-4                       (B)  derived from the results of a genetic test
 2-5     performed on that individual.
 2-6                 (4) [(3)]  "Genetic test" means a presymptomatic
 2-7     laboratory test of an individual's genes, gene products, [DNA, RNA,
 2-8     proteins,] or chromosomes to determine the presence or absence of a
 2-9     gene, or to identify by analysis of the individual's DNA, RNA,
2-10     proteins, or chromosomes, [the] genetic mutations or alterations
2-11     [in the DNA, RNA, proteins, or chromosomes] that are associated
2-12     with a statistically increased risk to develop [predisposition for]
2-13     a clinically recognized disease, [or] disorder, or syndrome or to
2-14     be a carrier of such a disease, disorder, or syndrome.  The term
2-15     does not include a blood test, cholesterol test, urine test, or
2-16     other physical test used for a purpose other than determining the
2-17     presence or absence of a gene in a specific individual[:]
2-18                       [(A)  a routine physical examination or a routine
2-19     test performed as a part of a physical examination;]
2-20                       [(B)  a chemical, blood, or urine analysis;]
2-21                       [(C)  a test to determine drug use; or]
2-22                       [(D)  a test for the presence of the human
2-23     immunodeficiency virus].
2-24                 (5) [(4)]  "RNA" means ribonucleic acid.
2-25           SECTION 2. Section 1, Article 21.73, Insurance Code, is
2-26     amended to read as follows:
2-27           Sec. 1.  DEFINITIONS. In this article:
 3-1                 (1)  "DNA" means deoxyribonucleic acid.
 3-2                 (2)  "Genetic characteristic" means a scientifically or
 3-3     medically identifiable gene or chromosome, or an alteration of such
 3-4     a gene or chromosome, that:
 3-5                       (A)  is scientifically or medically believed to:
 3-6                             (i)  predispose an individual to a disease,
 3-7     disorder, or syndrome; or
 3-8                             (ii)  be associated with a statistically
 3-9     significant increased risk of development of a disease, disorder,
3-10     or syndrome; and
3-11                       (B)  is not associated with any symptom of an
3-12     ongoing disease, disorder, or syndrome affecting an individual on
3-13     the date that genetic information is obtained regarding that
3-14     individual.
3-15                 (3)  "Genetic information" means information that is:
3-16                       (A)  obtained from or based on a scientific or
3-17     medical determination of the presence or absence in an individual
3-18     of a genetic characteristic; or
3-19                       (B)  derived from the results of a genetic test
3-20     performed on that individual.
3-21                 (4) [(3)]  "Genetic test" means a presymptomatic
3-22     laboratory test of an individual's genes, gene products, [DNA, RNA,
3-23     proteins,] or chromosomes to determine the presence or absence of a
3-24     gene, or to identify by analysis of the individual's DNA, RNA,
3-25     proteins, or chromosomes, [the] genetic mutations or alterations
3-26     [in the DNA, RNA, proteins, or chromosomes] that are associated
3-27     with a statistically increased risk to develop [predisposition for]
 4-1     a clinically recognized disease, [or] disorder, or syndrome or to
 4-2     be a carrier of such a disease, disorder, or syndrome.  The term
 4-3     does not include a blood test, cholesterol test, urine test, or
 4-4     other physical test used for a purpose other than determining the
 4-5     presence or absence of a gene in a specific individual[:]
 4-6                       [(A)  a routine physical examination or a routine
 4-7     test performed as a part of a physical examination;]
 4-8                       [(B)  a chemical, blood, or urine analysis;]
 4-9                       [(C)  a test to determine drug use; or]
4-10                       [(D)  a test for the presence of the human
4-11     immunodeficiency virus].
4-12                 (5) [(4)]  "Group health benefit plan" means a plan
4-13     described by Section 2 of this article.
4-14                 (6) [(5)]  "RNA" means ribonucleic acid.
4-15           SECTION 3. Section 1, Article 9031, Revised Statutes, as
4-16     added by Chapter 1215, Acts of the 75th Legislature, Regular
4-17     Session, 1997, is amended to read as follows:
4-18           Sec. 1.  DEFINITIONS. In this article:
4-19                 (1)  "DNA" means deoxyribonucleic acid.
4-20                 (2)  "Genetic characteristic" means a scientifically or
4-21     medically identifiable gene or chromosome, or an alteration of such
4-22     a gene or chromosome, that:
4-23                       (A)  is scientifically or medically believed to:
4-24                             (i)  predispose an individual to a disease,
4-25     disorder, or syndrome; or
4-26                             (ii)  be associated with a statistically
4-27     significant increased risk of development of a disease, disorder,
 5-1     or syndrome; and
 5-2                       (B)  is not associated with any symptom of an
 5-3     ongoing disease, disorder, or syndrome affecting an individual on
 5-4     the date that genetic information is obtained regarding that
 5-5     individual.
 5-6                 (3)  "Genetic information" means information that is:
 5-7                       (A)  obtained from or based on a scientific or
 5-8     medical determination of the presence or absence in an individual
 5-9     of a genetic characteristic; or
5-10                       (B)  derived from the results of a genetic test
5-11     performed on that individual.
5-12                 (4) [(3)]  "Genetic test" means a presymptomatic
5-13     laboratory test of an individual's genes, gene products [DNA, RNA,
5-14     proteins], or chromosomes to determine the presence or absence of a
5-15     gene, or to identify by analysis of the individual's DNA, RNA,
5-16     proteins, or chromosomes, [the] genetic mutations or alterations
5-17     [in the DNA, RNA, proteins, or chromosomes] that are associated
5-18     with a statistically increased risk to develop [predisposition for]
5-19     a clinically recognized disease, [or] disorder, or syndrome or to
5-20     be a carrier of such a disease, disorder, or syndrome.  The term
5-21     does not include a blood test, cholesterol test, urine test, or
5-22     other test used for a purpose other than determining the presence
5-23     or absence of a gene in a specific individual[:]
5-24                       [(A)  a routine physical examination or a routine
5-25     test performed as a part of a physical examination;]
5-26                       [(B)  a chemical, blood, or urine analysis;]
5-27                       [(C)  a test to determine drug use; or]
 6-1                       [(D)  a test for the presence of the human
 6-2     immunodeficiency virus].
 6-3                 (5) [(4)]  "Licensing authority" means a state agency
 6-4     or political subdivision that issues an occupational license.
 6-5                 (6) [(5)]  "Occupational license" means a license,
 6-6     certificate, registration, permit, or other form of authorization
 6-7     required by law or rule that must be obtained by an individual to
 6-8     engage in a particular business or occupation.
 6-9                 (7) [(6)]  "Political subdivision" means a
6-10     municipality, county, or special district or authority.  The term
6-11     includes a school district.
6-12                 (8) [(7)]  "RNA" means ribonucleic acid.
6-13                 (9) [(8)]  "State agency" means a department, board,
6-14     bureau, commission, committee, division, office, council, or agency
6-15     in the executive or judicial branch of state government.
6-16           SECTION 4. This Act takes effect September 1, 2001.
6-17           SECTION 5. Section 21.401, Labor Code, as amended by this
6-18     Act, applies only to a perfected complaint filed with the
6-19     Commission on Human Rights on or after the effective date of this
6-20     Act.  A perfected complaint filed before that date is governed by
6-21     the law in effect on the date that the complaint was filed, and the
6-22     former law is continued in effect for that purpose.
6-23           SECTION 6. Section 1, Article 21.73, Insurance Code, as
6-24     amended by this  Act, applies only to a health insurance policy or
6-25     an evidence of coverage that is delivered, issued for delivery, or
6-26     renewed on or after January 1, 2002.  A policy or evidence of
6-27     coverage that is delivered, issued for delivery, or renewed before
 7-1     January 1, 2002, is governed by the law as it existed immediately
 7-2     before the effective date of this Act, and that law is continued in
 7-3     effect for that purpose.
 7-4           SECTION 7. Section 1, Article 9031, Revised Statutes, as
 7-5     added by Chapter 1215, Acts of the 75th Legislature, Regular
 7-6     Session, 1997, and amended by this Act, applies only to a license
 7-7     issued or renewed by a licensing authority on or after the
 7-8     effective date of this Act.  A license issued or renewed before
 7-9     that date is governed by the law in effect on the date the license
7-10     was issued or renewed, and the former law is continued in effect
7-11     for that purpose.